The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.
                            本发明涉及 1,4-苯并
硫氮杂卓衍
生物及其用于治疗与调节细胞中
钙离子通道功能的雷诺丁受体(RyRs)有关的病症、紊乱和疾病的用途。本发明还公开了包含这些化合物的药物组合物及其用于治疗与RyRs相关的疾病和病症的用途,特别是心脏、肌肉骨骼和中枢神经系统(CNS)疾病。